RaySearch Laboratories AB (publ) announced the release of RayIntelligence v2025, a major update to its oncology analytics system designed to transform clinical data into actionable insights. With new tools for building customised dashboards and deeper integration across RaySearch's product portfolio—including RayStation and RayCare—the system enables clinics to continuously learn from patient journey data and improve treatment outcomes.

In most clinics, large volumes of oncology data are scattered across separate systems, which makes evidence-based improvements slow and fragile. By directly connecting to primary oncology data sources, RayIntelligence helps institutions learn from their own data and adapt their practice, assets, and skills on a continual basis.

With the new customisation tools, clinics can create dashboards that reflect their operations and priorities, from plan quality trends and machine utilisation to protocol adherence and outcome signals. RayIntelligence v2025 provides a single, comprehensible intelligence layer that equips clinical teams to run a self-improving oncology program, enabling clinics' readiness today and tomorrow.

Johan Löf, founder and CEO, RaySearch, comments: "Our vision for RayIntelligence has always been clear: to transform oncology data into a continuous source of insight. With v2025, we take a significant leap forward. By absorbing and processing data from every stage of the patient journey, the system empowers clinics to refine their treatments and operations over time—building a smarter, more adaptive oncology program for the future."